SCRI - Tennessee Oncology Nashville — Nashville, Tennessee

SCRI - Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Tennessee Oncology Nashville has participated in 1 clinical trials.

Therapeutic areas: Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer.

Sponsors: Epizyme, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Tennessee Oncology Nashville?

SCRI - Tennessee Oncology Nashville has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Tennessee Oncology Nashville conducted?

SCRI - Tennessee Oncology Nashville has 1 clinical trials on record. Their work covers Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer.

Is SCRI - Tennessee Oncology Nashville accredited by Crixeo Health?

SCRI - Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Tennessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.